SCHEMBL14938282

SCHEMBL14938282

Cn1nccc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PORCN Q9H237 2/20 0.55
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP19A1 P11511 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 1/20 0.53
NAAA Q02083 1/20 0.47
COMT P21964 1/20 0.46
SLC13A5 Q86YT5 1/20 0.44
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926262 0.96 NPC1 (0.56) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL14937987 0.83 CYP2A6 (0.52) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL21160163 0.82 ALDH1A1 (0.43) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL3447723 0.81 CYP1A2 (0.54) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL14937928 0.81 PORCN (0.47) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL14938310 0.81 PORCN (0.58) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL8809530 0.79 CYP1A2 (0.47) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL3489735 0.79 CYP1A2 (0.53) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL332440 0.79 CYP1A2 (0.53) PORCNCYP1A2CYP3A4CYP2D6CYP19A1
SCHEMBL16826278 0.79 CYP3A4 (0.53) PORCNCYP1A2CYP3A4CYP2D6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642626-B2 Ethinyl-pyrazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-02-04 US disclosed
EP-2599775-A1 ETHINYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE GABRE, GRIN3A, GRIK5 PORCN 1297/4885CYP1A2 835/4885CYP3A4 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.